Pharmaceutical Industry News

Data presented at ENDO 2013, the Endocrine Society's 95th Annual Meeting PR Newswire WASHINGTON, June 17, 2013 WASHINGTON, June 17, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:

The BauPost Group: Rule 8.3 Filing - Elan Corporation plc - 4 Hours ago

IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES Name of person dealing

all 2 news articles >>

Mylan NZ unit boosts profit, sales outpaced expenses - 5 Hours ago

Mylan New Zealand, the local unit of the world's third-largest generic-drug maker, boosted profit by two-thirds last year as sales growth outpaced expenses. Profit rose 62% to $9.4 million in the 12

Investor's Corner: Great Firms Spend A Bunch On R - 6 Hours ago

Many great stocks represent companies that spend heavily on research and development. A company with a consistent commitment to R&D will often outperform rivals that lack commitment — especially over

U.K. Researchers Win Hefty Grant For Anti-Clotting Drug - 6 Hours ago

Researchers in the U.K. have won funding for a new developmental drug that could help reduce the risk of life threatening blood clots. The anticoagulant drug, called ichorcumab, is in development by researchers

Coroner says cancer, drug use killed California 'Night Stalker' serial killer Richard - 6 Hours ago

SACRAMENTO, Calif. A form of cancer killed the serial killer known as the Night Stalker who terrorized Southern California in the mid-1980s, coroners officials said Monday. Richard Ramirez died June

American Express takes you places

Sponsored

No matter what the size of your company, where it is located or the business you are in, transactions can help your company grow, prosper or reinvent itself. The Ernst and Young Transaction professionals can play a critical role at every step of the deal lifecycle. Learn More

Market Report, "NovaDel Pharma, Inc. - Strategic SWOT Analysis Review", published - 5 Hours ago

(PR-inside.com) NovaDel Pharma, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains

New Report Available: AMAG Pharmaceuticals, Inc. (AMAG) - Financial and Strategic - 5 Hours ago

- Fast Market Research recommends "AMAG Pharmaceuticals, Inc. (AMAG) - Financial and Strategic SWOT Analysis Review" from GlobalData, now available AMAG Pharmaceuticals, Inc. (AMAG) - Financial and Strategic

ViroPharma said in crosshairs Investor's Business Daily - 5 Hours ago

The maker of "orphan" drugs for rare diseases may be a takeover target, Reuters said, citing sources close to several drugmakers. Big Pharma is interested in orphan drugs as patents on their blockbusters

Company shares information on the most effective ways to quit smoking - 5 Hours ago

Say no to cigarettes: Khor (right) explaining the Pledge To Quit Right campaign to Dr Subramaniam (centre) and Cheah. TO eradicate cigarette dependence in Malaysia, GlaxoSmithKline (GSK) participated

J&J expands pipeline in prostate cancer - 6 Hours ago

Johnson & Johnson is lining up prostate-cancer drug contenders. The multidisciplinary behemoth announced Monday that it was buying up Aragon Pharmaceutical's experimental androgen receptor antagonist

Valeant Pharmaceuticals Announces Public Offering Of Common Shares - 5 Hours ago

/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has filed a preliminary prospectus supplement to its effective shelf registration statement

For clinical research, technology is a life saver - 6 Hours ago

The journal Nature recently published a comment about the US clinical research system, arguing that it needs complete overhaul. The commentator was Arthur Ammann, a fine immunologist who developed the

Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations - 5 Hours ago

/PRNewswire/ -- Prime Therapeutics, in collaboration with public relations agency, Weber Shandwick, and branding and design agency, Larsen, was awarded the Silver Anvil for its internal communication

Mylan’s NZ unit boosts profit by 62% on demand for generics - 5 Hours ago

Mylan’s New Zealand unit boosts profit by two thirds as sales growth outpaces costs June 18 (BusinessDesk) – Mylan New Zealand, the local unit of the world’s third-largest generic-drug maker, boosted

all 1 news articles >>

N Korea?s Peace Treaty Talks Proposal Meets US Skepticism - 7 Hours ago

North Korea’s proposal for peace talks with the US spurred a skeptical response, days after the totalitarian regime failed to follow through on a similar approach to South Korea on discussions over a

all 2 news articles >>

MedImmune and NGM Biopharmaceuticals link for research on diabetes and obesity - 6 Hours ago

AstraZeneca today announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc. have entered into an exclusive agreement to discover, develop and commercialise

all 21 news articles >>

In Vitro and Ex Vivo Evaluation of Polymeric Nanoparticles for Vaginal and Rectal - 6 Hours ago

Prevention strategies such as the development of microbicides are thought to be valuable in the fight against HIV/AIDS. Despite recent achievements, there is still a long road ahead in the field, particularly

all 1 news articles >>

U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis - 6 Hours ago

Home » Press Releases » PARSIPPANY, N.J., June 17, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today announced that the United States Supreme Court has reversed the decision of the U.S. Court of Appeals